Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
Patents for C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
01/2014
01/23/2014US20140024640 Benzazepine Derivatives Useful as Vasopressin Antagonists
01/23/2014US20140024635 Inhibitors of the influenza a virus m2 proton channel
01/23/2014US20140024619 Benzazepine Derivatives Useful as Vasopressin Antagonists
01/22/2014EP2687507A1 Nitrogen-containing condensed heterocyclic compound
01/22/2014EP2687506A1 Method for enzymatic synthesis of (7S)-1-(3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-triene-7-yl) N-methyl methanamine, and use for the synthesis of Ivabradine and the salts thereof
01/22/2014CN103525453A Oxidative coupling extraction desulfurization of petroleum product as well as ionic liquid and preparation method thereof
01/22/2014CN103524415A One-step synthesis method for caprolactam from cyclohexanol, hydrogen peroxide and hydroxylamine
01/22/2014CN103523759A Process for the production of hydroxylamine by reduction of nitrate or nitrogen monoxide
01/21/2014US8633184 Benzoazepin-oxy-acetic acid derivatives as PPAR-delta agonists used for the increase of HDL-C, lower LDL-C and lower cholesterol
01/17/2014CA2820192A1 Enzymatic synthesis process for (7s)-1-(3,4-dimethoxy bicyclo[4.2.0]octa-1,3,5-triene 7-yl) n-methyl methanamine, and application to the synthesis of ivabradine and of its salts
01/16/2014WO2014009495A1 Antiproliferative benzo [b] azepin- 2 - ones
01/16/2014CA2877187A1 Antiproliferative benzo [b]azepin-2-ones
01/15/2014EP2683691A2 Process for the preparation of (s)-(+)-or (r)-(-)-10 hydroxy dihydrodibenz[b,f]azepines by enantioselective reduction of 10, 11-dihydro-10-oxo-5h-dibenz[b,f]azepines and polymorphs thereof
01/15/2014EP2683687A1 Primary amine diazeniumdiolate heterocyclic derivatives
01/15/2014CN103509025A Preparation method of epinastine hydrochloride and intermediate thereof
01/15/2014CN103508956A Method used for continuous conversion of epsilon-caprolactam from cyclohexanone-oxime mixture containing cyclohexanol
01/15/2014CN103508955A Method used for continuous conversion of epsilon-caprolactam from cyclohexanone-oxime
01/15/2014CN103508954A Crystallization and purification method and preparation method of caprolactam
01/09/2014WO2014008214A1 Biaryl-containing compounds as inverse agonists of ror-gamma receptors
01/09/2014WO2014007398A1 Cationic lipid
01/09/2014WO2013017582A9 Acetone solvate of ivabradine hydrochloride
01/08/2014CN102417481B Industrial method for producing iminodibenzyl from 2,2'-ethylenedianiline by catalytic deamination
01/07/2014US8623863 Disubstituted azepan orexin receptor antagonists
01/02/2014US20140005176 2-Phenoxy- and 2-Phenylsulfonamide Derivatives with CCR3 Antagonistic Activity for the Treatment of Inflammatory or Immunological Disorders
01/02/2014US20140005175 Substituted Aromatic Sulfur Compounds and Methods of Their Use
01/01/2014EP2678316A2 Substituted aromatic sulfur compounds and methods of their use
01/01/2014CN103492366A Primary amine diazeniumdiolate heterocyclic derivatives
01/01/2014CN103483488A Preparation method of resin catalyst for producing caprolactam
01/01/2014CN103483257A Method for synthesizing iminostilbene
01/01/2014CN102863385B Method for directly synthesizing caprolactam through cyclohexanone
01/01/2014CN102584702B Catalyst composition and method for preparing amide using the same
12/2013
12/31/2013CA2645756C Malonamide derivatives as gamma secretase inhibitors
12/26/2013US20130345198 Process for the preparation of (s)-(+)- or (r)-(-)-10-hydroxy dihydrodibenz[b,f]azepines by enantioselective reduction of 10,11-dihydro-10-oxo-5h-dibenz[b,f]azepines and polymorphs thereof
12/25/2013CN103476752A Substituted aromatic sulfur compounds and methods of their use
12/25/2013CN103467378A Process method for producing caprolactam by using recovered waste chinlon silks and leftovers and application of phosphoric acid serving as catalyst in process method
12/25/2013CN103467377A Preparation method of meptazinol hydrochloride critical impurity
12/25/2013CN103467376A New method for preparation of meptazinol hydrochloride critical impurity
12/24/2013US8614316 Optically active quaternary ammonium salt having axial asymmetry and process for producing α-amino acid and derivative thereof with the same
12/24/2013US8614209 Amido-thiophene compounds and their use
12/19/2013WO2013187406A1 Method for producing 4,4,7-trifluoro-1,2,3,4-tetrahydro-5h-1-benzazepine compound and intermediate for synthesis thereof
12/18/2013EP2674419A1 Quaternary ammonium salt
12/18/2013CN103450082A Novel method for synthesising ivabradine and its pharmaceutically acceptable acid addition salts
12/18/2013CN103450081A Preparation method of meptazinol hydrochloride intermediate 1-methyl-3-(3-oxo-1-cyclohexyl-1-alkenyl)-6H-azepin-2-one
12/12/2013WO2013183642A1 Axially chiral pyridine derivative or salt thereof, and method for producing same and chiral catalyst comprising same
12/12/2013WO2013182263A1 Phenanthrene compounds for organic electronic devices
12/11/2013EP2671869A1 Tetrahydroisoquinoline derivative
12/11/2013CN103435549A 5-methyl-7-amino-5H,7H-dibenzo[b,d]azepin-6-ketone preparation method
12/11/2013CN102603633B Gasification system for preparing cyclohexanone oxime in caprolactam by Beckmann gas phase rearrangement
12/05/2013WO2013150544A3 Ivabradine hydrochloride solid dispersion
12/04/2013CN103420914A Preparation method for novel pesticide penetration promoter N-n-butyl caprolactam
12/04/2013CN103420913A Crystallization refining method and preparation method of caprolactam
12/04/2013CN103420912A Epsilon-caprolactam crude product crystallization method and caprolactam preparation method
12/04/2013CN103420911A L-meptazinol phenyl carbamate-L-(+)-tartrate and preparation method thereof
12/04/2013CN103420885A Epsilon-caprolactam crude product crystallization method and caprolactam preparation method
11/2013
11/28/2013US20130317010 Tetrahydroisoquinoline derivative
11/28/2013US20130317005 Non-hygroscopic salts of 5-ht2c agonists
11/27/2013CN102626645B Application of fluorgypsum in ketoxime Beckmann rearrangement
11/21/2013WO2013171484A1 Crystallisation process
11/20/2013EP2663555A2 Substituted benzoazepines as toll-like receptor modulators
11/20/2013EP2663550A2 Substituted benzoazepines as toll-like receptor modulators
11/20/2013CN203295402U Caprolactam polymer monomer recovery system
11/20/2013CN103393691A Anti-inflammatory agents
11/19/2013US8586575 Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder
11/14/2013WO2013167985A1 Compositions and methods for the treatment of neurological disorders
11/14/2013WO2013117869A3 Method for enzymatically synthesizing (7s)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-triene-7-carboxylic acid or the esters thereof, and use in the synthesis of ivabradine and the salts thereof
11/13/2013CN102432539B Crystallization separation method in process of producing iminostilbene through catalytic dehydrogenation of iminodibenzyl
11/12/2013US8580780 6 substituted 2, 3,4,5 tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonist
11/06/2013CN103384660A Method for producing high-quality epsilon-caprolactam
11/05/2013US8575149 5HT2C receptor modulators
11/05/2013US8575143 3-aryl-substituted quinazolones, and uses thereof
11/05/2013US8574569 Stabilized protease composition
11/05/2013CA2589147C A process for the preparation of (s)-(+)-10,11-dihydro-10-hydroxy-5h-dibenz (b,f) azepine-5-carboxyamide
10/2013
10/30/2013CN203256182U Extraction and recovering device for intermediate
10/30/2013CN103373960A Tolvaptan intermediate and preparation method thereof
10/30/2013CN101654436B Method for producing epsilon caprolactam and method for producing pentasil type zeolite
10/24/2013US20130281294 Use of sarmentine and its analogs for controlling plant pests
10/22/2013US8563713 Antibodies specific to carbamazepine
10/22/2013CA2619450C 6-n-linked heterocycle-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
10/22/2013CA2619287C 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
10/17/2013WO2013152999A1 Process for the preparation of caprolactam
10/17/2013US20130274248 Compound Having Activity Of Blocking NMDA Receptor Channel, and Pharmaceutical Agent Using The Same
10/16/2013EP2649048A1 Multifunctional nitroxide derivatives and uses thereof
10/16/2013CN102030709B Benzazepines compounds serving as vasopressin receptor antagonism
10/16/2013CN101146812B Optically active ammonium salt compound, production intermediate thereof and method for producing same
10/10/2013WO2013149704A1 Cyclic amides as metap-2 inhibitors
10/10/2013US20130267699 Quaternary heteroatom containing compounds
10/09/2013CN103347861A 季铵盐 Quaternary
10/09/2013CN103347856A Multifunctional nitroxide derivatives and uses thereof
10/09/2013CN103342680A Benzazepine derivatives useful as vasopressin antagonists
10/09/2013CN103342679A Benzazepine derivatives useful as vasopressin antagonists
10/08/2013CA2750089C Novel method for the synthesis of ivabradine and the pharmaceutically acceptable acid addition salts thereof
10/08/2013CA2706171C Fused indane compound
10/03/2013WO2013146437A1 3-decenoic acid derivative and use for same
10/03/2013WO2013144500A1 Novel method for synthesizing ivabradine and its addition salts with a pharmaceutically acceptable acid
10/03/2013WO2013102919A4 Polymorphic forms of ivabradine hydrochloride
10/03/2013US20130261298 Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
10/03/2013US20130261296 Catalyst complex with carbene ligand
10/02/2013EP2644597A1 Novel method for synthesising ivabradine and its pharmaceutically acceptable acid addition salts
10/02/2013CN103339109A Tetrahydroisoquinoline derivative
10/02/2013CN103333111A Preparation method of lorcaserin hydrochloride
1 2 3 4 5 6 7 8 9 10 11 12 13 14 ... 88